Skip to content

Science & Technology

Engineering the microbiome into reproducible medicine.

We treat the gut microbiome as a programmable drug class — directed at the gut–brain–immune axis across CNS and oncology.

Definition

Microbiome-as-a-Drug

Microbiome-as-a-Drug is the approach of treating defined, functional gut microbiota — and their metabolites — as a controllable therapeutic class rather than a supplement. It pairs an industrialized, standardized process (FMT 3.0, P2 + GMP) with a proprietary strain library and AI-native discovery, so that microbiome interventions can be dosed, traced and studied like a medicine.

The gut–brain–immune axis

Gut–brain (CNS)

The microbiome modulates neuro-active metabolites and signaling along the gut–brain axis — the basis for our depression & mood-disorder programs.

Gut–immune (Oncology)

Gut microbiota shape systemic immunity — a lever to sensitize otherwise “cold” tumors to immune-checkpoint therapy and to limit metastasis.

AI-native

AI as infrastructure, not a tool

We are an AI-native biotech — AI runs across five dimensions of how we operate and discover, anchored by our gut-microbiome data base.

01

Governance

AI-assisted decision-making and risk control across the organization.

02

Data

A gut-microbiome data base unifying metagenomics, metabolomics, clinical phenotype and immune profiles.

03

R&D planning

Target discovery, trial design and knowledge-graph mining to shorten cycles.

04

Molecule & strain engineering

Predicting strain metabolite activity and safety to guide rational selection and design.

05

Biomanufacturing

Real-time fermentation monitoring and digital-twin process control from pilot to scale.

Strain library & 16S platform

300+ reserved functional strains, characterized and screened on a 16S platform that feeds the discovery pipeline.

Industrialized FMT 3.0

A freeze-dried, capsule-based process manufactured under P2 + GMP with triple-encapsulation for strain viability — standardized and room-stable.

See aFMT →

The science is backed by evidence.

Clinical case narratives and expert consensus, each with a cited source.